Exosomal miR-106b serves as a novel marker for lung cancer and promotes cancer metastasis via targeting PTEN

被引:53
作者
Sun, Shifang [1 ]
Chen, Hailin [2 ]
Xu, Chenlei [3 ]
Zhang, Yun [1 ]
Zhang, Qiaoli [1 ]
Chen, Lei [1 ]
Ding, Qunli [1 ]
Deng, Zaichun [1 ]
机构
[1] Ningbo Univ, Affiliated Hosp, Med Sch, Dept Resp, 247 Renmin Rd, Ningbo 315020, Zhejiang, Peoples R China
[2] Ningbo Univ, Affiliated Hosp, Med Sch, Dept Clin Lab, Ningbo, Zhejiang, Peoples R China
[3] Ningbo Univ, Affiliated Hosp, Med Sch, Dept Clin Pharmacol, Ningbo, Zhejiang, Peoples R China
关键词
Lung cancer; Exosome; miR-106b; PTEN; Migration; Invasion; INHIBITS APOPTOSIS; CELL; PROLIFERATION; PI3K/AKT;
D O I
10.1016/j.lfs.2020.117297
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
As novel non-invasive tumor diagnostic biomarkers, exosomal bioactive miRNAs have received increasing attention. Herein, the aim of this study is to explore the clinical values and roles of exosomal miR106b in lung cancer. The exosomal miR-106b level was much higher in the serum of patients with lung cancer than that in healthy volunteers. Also, the exosomal miR-106b level in the lung cancer patient serum was associated with TNM stages and lymph node metastasis. Furthermore, exosomal miR-106b enhanced the migrated and invasive ability of lung cancer cells and increased the MMP-2 and MMP-9 expression. Mechanistically, exosomal miR-106b could target PTEN, and promote lung cancer cell migration and invasion. More importantly, PTEN overexpression reversed the effect of exosomal miR-106b on lung cancer cell migration and invasion. Taken together, these findings indicate that exosomal miR-106b may be a promising diagnostic biomarker and drug target for patients with lung cancer.
引用
收藏
页数:7
相关论文
共 24 条
[21]   MicroRNA-106b-5p regulates cisplatin chemosensitivity by targeting polycystic kidney disease-2 in non-small-cell lung cancer [J].
Yu, Shaorong ;
Qin, Xiaobing ;
Chen, Tingting ;
Zhou, Leilei ;
Xu, Xiaoyue ;
Feng, Jifeng .
ANTI-CANCER DRUGS, 2017, 28 (08) :852-860
[22]  
Yue QY, 2019, EUR REV MED PHARMACO, V23, P6211, DOI 10.26355/eurrev_201907_18438
[23]   Detection of circulating exosomal miR-17-5p serves as a novel non-invasive diagnostic marker for non-small cell lung cancer patients [J].
Zhang, Yi ;
Zhang, Yingmei ;
Yin, Yunhong ;
Li, Shuhai .
PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (08)
[24]  
Zhu Zhenglun, 2019, Cell Physiol Biochem, V52, P606, DOI 10.33594/000000043